Each filer's latest filing for 74587V107 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
| Alan H. Auerbach 13D/A | 16.0% |
10/6/2026
Event 10/4/2026
|
||
|
Acorn Bioventures, L.P.
13G/A
|
8.0% |
2/14/2025
Event 12/31/2024
|
||
| Acorn Bioventures, L.P. | 3.3% | |||
| Acorn Bioventures 2, L.P. | 4.7% | |||
| Acorn Capital Advisors GP, LLC | 3.3% | |||
| Anders Hove | 8.0% | |||
| Acorn Capital Advisors GP 2, LLC | 4.7% | |||
| BlackRock, Inc. 13G/A | 5.6% |
4/17/2025
Event 3/31/2025
|
||
|
American Century Investment Management, Inc.
13G
|
5.3% |
11/16/2026
Event 9/30/2026
|
||
| American Century ETF Trust | 5.1% | |||
| American Century Investment Management, Inc. | 5.3% | |||
| American Century Companies, Inc. | 5.3% | |||
| Stowers Institute for Medical Research | 5.3% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Millennium Management LLC
13G/A
|
3.9% |
2/3/2025
Event 12/31/2024
|
||
| Integrated Core Strategies (US) LLC | 2.8% | |||
| Millennium Management LLC | 3.9% | |||
| Millennium Group Management LLC | 3.9% | |||
| Israel A. Englander | 3.9% | |||
|
Camber Capital Management LP
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| Camber Capital Management LP | 0% | |||
| Stephen DuBois | 0% | |||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
|
0% |
2/14/2025
Event 12/31/2024
|
||
| Frazier Life Sciences Public Fund, L.P. | 0% | |||
| FHMLSP, L.P. | 0% | |||
| FHMLSP, L.L.C. | 0% | |||
| Frazier Life Sciences X, L.P. | 0% | |||
| FHMLS X, L.P. | 0% | |||
| FHMLS X, L.L.C. | 0% | |||
| Frazier Life Sciences XI, L.P. | 0% | |||
| FHMLS XI, L.P. | 0% | |||
| FHMLS XI, L.L.C. | 0% | |||
| James N. Topper | 0% | |||
| Patrick J. Heron | 0% | |||
| Albert Cha | 0% | |||
| James Brush | 0% | |||
| Daniel Estes | 0% | |||
| Vanguard Group Inc 13G/A | 0% |
3/27/2026
Event 3/13/2026
|
||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 160 | 40.4 M | $402M |
| 2026 Q2 | 161 | 38.7 M | $314M |
| 2026 Q1 | 158 | 37.9 M | $242M |
| 2025 Q4 | 153 | 35.3 M | $210M |
| 2025 Q3 | 136 | 34.4 M | $183M |
| 2025 Q2 | 122 | 32.8 M | $113M |
| 2025 Q1 | 118 | 30.4 M | $90.0M |
| 2024 Q4 | 113 | 29.4 M | $89.7M |
| 2024 Q3 | 102 | 29.7 M | $75.8M |
| 2024 Q2 | 100 | 31.0 M | $101M |
| 2024 Q1 | 97 | 29.7 M | $158M |
| 2023 Q4 | 83 | 26.6 M | $115M |
| 2023 Q3 | 71 | 25.7 M | $67.6M |
| 2023 Q2 | 70 | 26.6 M | $93.8M |
| 2023 Q1 | 79 | 27.9 M | $86.1M |
| 2022 Q4 | 90 | 27.5 M | $116M |
| 2022 Q3 | 84 | 27.7 M | $65.5M |
| 2022 Q2 | 90 | 27.9 M | $79.5M |
| 2022 Q1 | 106 | 29.9 M | $86.1M |
| 2021 Q4 | 103 | 30.3 M | $92.2M |
| 2021 Q3 | 118 | 32.2 M | $226M |
| 2021 Q2 | 122 | 34.8 M | $319M |
| 2021 Q1 | 119 | 36.6 M | $356M |
| 2020 Q4 | 125 | 35.3 M | $362M |
| 2020 Q3 | 129 | 36.1 M | $364M |
| 2020 Q2 | 131 | 35.1 M | $366M |
| 2020 Q1 | 128 | 36.6 M | $309M |
| 2019 Q4 | 136 | 31.3 M | $274M |
| 2019 Q3 | 146 | 36.6 M | $394M |
| 2019 Q2 | 141 | 35.0 M | $445M |
| 2019 Q1 | 162 | 34.2 M | $1.32B |
| 2018 Q4 | 143 | 35.2 M | $717M |
| 2018 Q3 | 158 | 35.9 M | $1.64B |
| 2018 Q2 | 176 | 36.2 M | $2.13B |
| 2018 Q1 | 179 | 35.6 M | $2.42B |
| 2017 Q4 | 205 | 36.2 M | $3.61B |
| 2017 Q3 | 174 | 36.7 M | $4.39B |
| 2017 Q2 | 160 | 35.5 M | $3.10B |
| 2017 Q1 | 139 | 38.0 M | $1.41B |
| 2016 Q4 | 130 | 34.9 M | $1.07B |
| 2016 Q3 | 153 | 30.0 M | $2.01B |
| 2016 Q2 | 111 | 31.8 M | $948M |
| 2016 Q1 | 121 | 30.4 M | $893M |
| 2015 Q4 | 136 | 32.2 M | $2.52B |
| 2015 Q3 | 165 | 30.2 M | $2.27B |
| 2015 Q2 | 201 | 30.5 M | $3.55B |
| 2015 Q1 | 202 | 29.1 M | $6.87B |
| 2014 Q4 | 190 | 27.1 M | $5.14B |
| 2014 Q3 | 187 | 26.7 M | $6.37B |
| 2014 Q2 | 141 | 25.4 M | $1.68B |
| 2014 Q1 | 138 | 25.1 M | $2.62B |